Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(6 sites)
Australia
St Leonards, Saint Leonards, New South Wales (nsw) Coorparoo, Coorparoo, Queensland South Yarra, South Yarra, Victoria New Zealand
Auckland, Auckland, Auckland Christchurch, Christchurch, Canterbury Palmerston North, Palmerston North, Palmerston North Central